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Abstract The aim of the study was to evaluate the presence
and spectrum of cardiac abnormalities identified by cardiac
magnetic resonance (CMR) in subjects in clinical remission of
Churg–Strauss syndrome (CSS) and granulomatosis with pol-
yangiitis (Wegener’s) (WG) with normal ECG and transtho-
racic echocardiography (TTE). Eleven (7 females, 4 males,
mean age 42.4 ± 9.6 years) CSS and 10 (4 females, 6 males,
mean age 45.3 ± 10.9 years) WG patients in clinical remission
with normal ECG and TTE underwent CMR. Segmental peak-
systolic myocardial strain (eps) was measured using feature
tracking cine-sequence based technique. Left ventricular
(LV) ejection fraction, end-diastolic volume and myocardial
mass indexes were 66.2 ± 5.8 %, 66.1 ± 6.6 ml/m2, and
61.0 ± 8.9 g/m2, respectively. No patient showed regional
wall motion abnormalities and signs of myocarditis. Nine CSS
and 8 WG patients demonstrated decreased segmental longi-
tudinal, circumferential or radial eps and myocardial late gad-
olinium enhancement (LGE) (6 subendocardial, 10 midwall, 8
subepicardial) areas. In CSS and WG subjects with LVLGE
lesions the mean LVLGE extent was 2.0 ± 1.6 % and
2.3 ± 1.5 % (p = 0.65), respectively. Segmental eps was
decreased longitudinally (-11.8 ± 5.6 %) for subendocardial
LGE, radially (13.7 ± 8.7 %) for subepicardial LGE, and
circumferentially (-16.6 ± 4.2 %), longitudinally (-13.2 ±
5.5 %) and radially (18.8 ± 8.1 %) for midwall LGE, if
compared to longitudinal (-22.7 ± 5.1 %), circumferential
(-23.6 ± 5.6 %) and radial (34.2 ± 15.7 %) eps in controls
(11 females, 10 males, mean age 43.9 ± 10.5 years) (all
p\ 0.01). Despite clinical remission, normal ECG and TTE,
most CSS and WG patients demonstrate decreased segmental
eps and non-ischemic LGE lesions without signs of myocarditis.
Keywords Churg–Strauss syndrome  Granulomatosis
with polyangiitis (Wegener’s)  Cardiac magnetic
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Introduction
Churg–Strauss syndrome (CSS) and granulomatosis with
polyangiitis (Wegener’s) (WG) represent the rare group of
antineutrophil cytoplasmic antibodies (ANCA) associated
small vessel necrotizing vasculitis, which may affect
the heart [1]. Although clinically evident cardiac mani-
festations in WG and CSS are rare, heart involvement is
not uncommon and is associated with poor outcome [1].
A wide spectrum of cardiac abnormalities has been docu-
mented in the course of CSS and WG including myo-
carditis, coronary vasculitis, valvular heart disease, peri-
carditis and/or rhythm disorders [1]. The frequency of
cardiac involvement varies depending on the level of dis-
ease activity and the diagnostic test employed. The ECG
and transthoracic echocardiography (TTE) are the most
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often used screening tools for heart evaluation [2].
Recently, cardiac magnetic resonance (CMR) has emerged
as a novel non-invasive imaging modality providing com-
prehensive and accurate evaluation of myocardial function
and structure. Moreover, a new feature tracking cine-
sequence based CMR technique for strain measurement has
been recently developed and validated to provide insight
into intrinsic function of myocardial fibers [3, 4]. The prior
studies have shown that strain abnormalities are sensitive
markers of contractile dysfunction which may precede a
decline in ejection fraction (EF) [4]. Moreover, we have
reported that global left ventricular strain measured by
speckle tracking echocardiography might be used to depict
heart involvement in CSS and WG [5, 6]. To date, the use
of CMR to detect myocardial abnormalities in small vessel
necrotizing vasculitis has been limited to a few studies and
several case reports [7–18]. It has been suggested that
despite normal ECG and TTE, subclinical myocardial
involvement detected by CMR in clinical remission may be
common [7, 14]. Therefore, the aim of this study was to
evaluate the spectrum of cardiac abnormalities identified
by standard CMR in CSS and WG patients with normal
ECG and TTE, and to assess the presence of strain
abnormalities in this group of patients.
Methods
Study population
Twenty-one consecutive patients with CSS and WG in clinical
remission were enrolled prospectively. CSS and WG was
diagnosed according to the American College of Rheuma-
tology criteria [19, 20]. Clinical remission was defined as
Birmingham vasculitis activity scores (version 3) B 1 in
subjects with CCS and Birmingham vasculitis activity score
for WG B 1 in subjects with WG [21, 22]. Exclusion criteria
included: (a) limited WG (b) abnormal ECG (presence of
pathologic Q wave, ST segment abnormalities and/or rhythm
disorders) (c) abnormal TTE [left ventricular (LV) EF\50 %,
segmental wall motion abnormality, moderate/severe valve
regurgitation/stenosis and/or pericardial effusion], and
(d) contraindication to CMR including MR-incompatible
implants or electronic devices, renal insufficiency (creatinine
clearance \60 ml/kg/min), inability to perform breath hold
and claustrophobia. The cumulative organ involvement was
measured using Disease Extent Index (DEI) [23]. ANCA was
determined by indirect immunofluorescence technique, and
when positive, an enzyme-linked immunosorbent assay
(ELISA, Euroimmunn, Germany) was performed to detect
proteinase-3 (PR-3) and/or myeloperoxidase (MPO) ANCA.
The study was approved by institutional ethics committee.
Informed consent was obtained from each patient.
TTE
TTE was performed using Vivid 7 system (GE Vingmed
Ultrasound A/S, Horten, Norway) and analyzed off-line by
an independent, experienced viewer, unaware of clinical
and CMR data.
CMR: imaging protocol
Breath-hold, ECG-gated CMR was performed on 1.5 T scan-
ner (Magnetom Sonata Maestro Class, Siemens, Erlangen,
Germany) equipped with cardiac phased array coil. Cine and
morphologic imaging was performed in LV two-chamber,
four-chamber and long-axis apical views as well as in short-axis
views encompassing the entire LV and right ventricular (RV)
myocardium. Cine imaging was obtained using balanced
steady-state free precession gradient echo (slice/gap thick-
ness = 8/0 mm, matrix = 256 9 192, in-plane resolution =
1.4 9 1.4 mm2, TR/TE = 39/1.1 ms, flip angle = 59).
Morphologic images were acquired with T2-weighted short tau
inversion recovery (STIR) (slice/gap thickness = 8/0 mm,
matrix = 256 9 192, in-plane resolution = 1.4 9 1.4 mm2,
TR depending upon RR interval, TE = 65 ms, flip
angle = 180) and T1-weighted turbo spin echo imaging
(slice/gap thickness = 8/0 mm, matrix = 256 9 192,
in-plane resolution = 1.4 9 1.4 mm2, TR depending upon
RR interval, TE = 6.9 ms, flip angle = 180). T1-weighted
imaging was performed before and early after intravenous
infusion of 0.1 mmol/kg body weight gadobutrol (Gadovist,
Bayer Schering Pharma, Berlin, Germany). Following contrast
injection (10 min), late gadolinium-enhancement (LGE)
imaging was performed using T1-weighted segmented inver-
sion-recovery pulse sequence (slice/gap thickness = 8/0 mm,
matrix = 256 9 192, in-plane resolution = 1.4 9 1.4 mm2,
TR/TE = 650/4.9 ms, flip angle = 30, TI to null normal
myocardium).v
CMR: image analysis
Cine, T1-weighted pre- and after-contrast, T2-weighted
STIR, and LGE images were assessed off-line (MASS
Medis, Leiden, the Nedtherlands) by independent observer,
blinded to clinical and echocardiographic data using 16 LV
and 9 RV segment models [24].
Cine images
As previously described endocardial and epicardial RV and
LV borders were outlined on short-axis images to calculate
EF as well as end-diastolic volume (EDV), end-systolic
volume (ESV) and myocardial mass, which were indexed
to body surface area [24].
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T1-weighted and STIR images
By quantitative analysis mean T2 and T1 signal intensity
(SI) (pre- and post-contrast) were measured in (a) individ-
ual LV segments (b) entire LV myocardium at mid LV
level in short axis view and (c) skeletal muscle (erector
spinae/lattisimus dorsi) in the same slice, as previously
described [8]. T2 myocardial SI was related to skeletal
muscle SI and T2-SI ratio was calculated. Myocardial early
gadolinium enhancement (EGE) ratio was calculated as
myocardial to skeletal muscle enhancement ratio. Global
(i.e. determined in entire LV myocardium) T2-SI ratio
C2.0 and global EGE ratio C4 were considered abnormal
and indicative of myocardial edema and myocardial
hyperemia/hyperpermeability of capillaries, respectively
[25]. By analogy, T2-SI ratio C2.0 and EGE ratio C4 were
considered abnormal for individual LV segments.
LGE images
LGE images were assessed qualitatively for the presence
and location of hyperintense lesions in contrast to hypo-
intense viable myocardium. LGE lesions in LV myocar-
dium were defined as transmural, subendocardial (adjacent
to endocardium), midwall and subepicardial (adjacent to
epicardium) [25]. Based on visual assessment of distribu-
tion they were classified as non-ischemic or ischemic. LGE
size was assessed manually with planimetry on short-axis
slices, delineating hyper enhanced areas. The volume of
LGE lesions was calculated and their extent was expressed
as the percentage of myocardial volume.
Myocardial inflammation
According to Lake Louise Criteria CMR was considered to
indicate myocardial inflammation, when C2 of following
criteria were present: (a) global T2-SI ratio C2.0 (b) global
EGE ratio C4 and (c)C1 focal non-ischemic LGE lesion
[25].
Myocardial strain analysis
Myocardial strain analysis was performed using Diogenes
CMR feature tracking software (TomTec Imaging Systems,
Munich, Germany) applied to two-, three- and four-
chamber long axis as well as apical, mid and basal short
axis cine images. The subendocardial contours were drawn
manually at the end-diastolic frame and then automatically
propagated throughout the cardiac cycle. The contouring
was manually adjusted to delineate endocardium in every
segment at each cine frame, if automatic tracking of
endocardial border failed. If after contour adjustment the
endocardial border was not accurately tracked throughout
the entire cardiac cycle, the segment was considered une-
valuable. Myocardial strain was measured using feature
tracking technique in 4 pixels neighborhood and radial
strain was related to automatically detected epicardial
border. The segmental longitudinal, circumferential and
radial peak systolic strain (eps) was measured using 16
segment LV model by an independent observer blinded to
clinical and other CMR data. If according to consensus of
two experienced observers the course of segmental strain
curve at systolic phase was considered to be substantially
interfered with artifacts the segment was excluded from
analysis.
To determine intraobserver variability 10 randomly
selected studies were reevaluated 2 month later by the
same observer unaware of prior results. To assess inter-
observer variability the images were evaluated by the
second observer blinded to the results obtained by first one.
To determine the range of normal segmental eps CMR was
performed in 10 age- and sex-matched healthy volunteers.
Statistical analysis
Categorical data are presented as numbers (percentages),
while continuous data as mean ± SD or median with
interquartile range, where appropriate. The normal distri-
bution was verified using Kolmogorov–Smirnov test.
Categorical variables were compared by Fisher’s exact, Chi
square or Cochran Q test, while continuous variables by
unpaired/paired student t test and Wilcoxon rank-sum test,
where appropriate. Pearson product-moment correlation
was performed to assess relationship between the LVLGE
extent/volume and parameters reflecting disease activity.
The cut-off value for decreased eps was 5th percentile for
positive and 95th percentile for negative eps values mea-
sured in healthy individuals. The subject was classified as
having reduced segmental eps when C2 LV segments
demonstrated decreased eps. Inter- and intraobserver vari-
ability of eps measurement was assessed using Bland–
Altman method. Statistical analyses were performed using
SPSS software (version 12.0, SPSS Inc., Chicago, IL,
USA) with p \ 0.05 considered statistically significant.
Results
Study group
Eleven CSS patients (7 females, 4 males, mean age
42.4 ± 9.6 years) and 10 WG patients (4 females, 6 males,
mean age 45.3 ± 10.9 years) were enrolled (Tables 1, 2).
No CSS or WG patient demonstrated heart failure or
angina symptoms at enrollment. Three CSS and 2 WG
patients had developed clinical cardiac manifestations in
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Table 1 Patient characteristics
CCS (n = 11) / WG (n = 10) p
Female/male 7/4 / 4/6 0.39
Age [years] 42.4 ± 9.6 / 45.3 ± 10.9 0.30
Time since diagnosis [years] 4.7 ± 2.8 / 4.8 ± 3.9 0.99
Enrolment
Positive cANCA/pANCA 0/3 / 10/2 0.02
ANCA titrea 20 (20–30) / 20 (12.5–70) 0.81
PR3-ANCA titrea 0 (0–0) / 20 (20–40) \0.001
White blood cells [103cells/ll] 7.5 ± 3.7 / 7.5 ± 2.9 0.99
Blood eosinophilia [cells/ll] 198 ± 128 / 121 ± 53 0.09
CRP [mg/l] 3.2 ± 2.9 / 5.8 ± 5.3 0.12
Creatinine clearance [ml/min] 92 ± 18 / 101 ± 41 0.52
Positive troponin I 0 / 0 [0.99
Treatment: C/M/Az/Cy 1/0/2/2 / 3/1/0/0 0.20
Treatment: G 11/10 [0.99
Prior flare(s)
Ever positive cANCA/pANCA 0/3 / 10/2 0.02
Max ANCA titrea 40 (30–100) / 200 (80–560) 0.16
Max PR3-ANCA titrea 0 (0.0–0.0) / 200 (40–320) \0.001
Max white blood cells [103cells/ll] 15.5 ± 9.7 / 14.6 ± 5.3 0.79
Max blood eosinophilia [cells/ll] 6964 ± 8552 / 227 ± 72 0.02
Max CRP [mg/l] 37.0 ± 11.6 / 86.7 ± 55.1 0.009
Min creatinine clearance [ml/min] 84.7 ± 18.3 / 87.2 ± 40.6 0.86
Ever treated: C 9/10 0.48
Ever treated: G 11/10 [0.99
Az azathioprine, C cyclophosphamide, Cy cyclosporine, G glucocorticoids, M methotrexate, Max maximal, Min minimal
a median with interquartile range for patients with positive ANCA
Table 2 Cumulative organ involvement in subjects with CSS and WG with regard to presence of prior clinical cardiac manifestation
Organ involvement CSS WG All
Heart (?) / Heart (-)
(n = 3) / (n = 8)
p Heart (?) / Heart (-)
(n = 2) / (n = 8)
p CCS / WG
(n = 11) / (n = 10)
p
Upper respiratory tract 3 / 8 [0.99 2 / 8 [0.99 11 / 10 [0.99
Bronchial asthma 3 / 8 [0.99 0 / 0 [0.99 11 / 0 \0.001
Lung 3 / 7 [0.99 1 / 8 0.20 10 / 9 [0.99
Kidney 0 / 4 0.24 1 / 6 [0.99 4 / 7 0.20
Skin 1 / 6 0.49 0 / 4 0.47 7 / 4 0.39
Heart 3 / 0 0.006 2 / 0 0.02 3 / 2 [0.99
Eye 0 / 0 [0.99 0 / 2 [0.99 0 / 2 0.21
Gastrointestinal tract 0 / 3 0.49 0 / 2 [0.99 3 / 2 [0.99
Peripheral nervous system 1 / 5 0.54 1 / 2 [0.99 6 / 3 0.39
Central nervous system 0 / 1 [0.99 1 / 0 0.20 1 / 1 [0.99
Rheumatic complications 2 / 4 [0.99 0 / 3 [0.99 6 / 3 0.39
Constitutional symptoms 3 / 7 [0.99 2 / 5 [0.99 10 / 7 0.31
Cumulative DEI 9.7 ± 3.1 / 10.4 ± 1.6 0.62 9.0 ± 2.8 / 9.4 ± 2.4 0.89 10.2 ± 1.9 / 9.3 ± 3.2 0.45
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course of their disease. Of those, all CSS patients presented
with perimyocarditis (one with sudden cardiac arrest),
while one WG patient developed myocarditis and one
non ST-segment elevation myocardial infarction without
obstructive epicardial coronary artery stenoses. Six patients
reported cigarette smoking, 9 hypertension, 9 hypercho-
lesterolemia, 1 diabetes mellitus and 1 obesity (body mass
index C30 kg/m2). All patients had normal 12-lead ECG.
None of the patients demonstrated LVEF \50 %, seg-
mental wall motion abnormalities, moderate/severe valve
Table 3 CMR findings in subjects with CSS, WG and controls
CMR parameters CSS (n = 11) / WG (n = 10) p All (n = 21) / Controls (n = 21) p
LVEF [%] 68.0 ± 6.1 / 66.0 ± 5.0 0.89 66.2 ± 5.8 / 63.4 ± 3.4 0.13
LVEDV index [ml/m2] 66.1 ± 4.0 / 66.1 ± 8.5 0.99 66.1 ± 6.6 / 69.9 ± 8.2 0.15
LV mass index [g/m2] 56.9 ± 7.8 / 65.5 ± 8.6 0.02 61.0 ± 8.9 / 49.7 ± 7.8 \0.001
RVEF [%] 63.7 ± 3.7 / 58.9 ± 6.3 0.05 61.4 ± 5.7 / 60.3 ± 7.1 0.60
RVEDV index [ml/m2] 68.0 ± 6.9 / 69.6 ± 9.0 0.65 68.8 ± 7.8 / 71.9 ± 8.3 0.28
RV mass index [g/m2] 17.8 ± 3.2 / 16.7 ± 1.9 0.36 17.3 ± 2.5 / 17.6 ± 2.2 0.68
Myocardial SI-T2 ratio at mid LV
level
1.2 ± 0.2 / 1.3 ± 0.2 0.33 1.3 ± 0.2 / 1.2 ± 0.3 0.37
Myocardial EGE ratio at mid LV level 2.2 ± 0.8 / 2.3 ± 0.3 0.71 2.2 ± 0.6 / 2.2 ± 0.9 0.88
Pericardial effusion 2 / 2 [0.99 4 / 0 0.11
Localized pericardial thickening 2 / 4 0.36 6 / 0 0.02
Decreased eps C2 LV segments 9 / 8 [0.99 17 / 0 \0.001
Decreased eps: total (mean) LV
segment number
66 (6.0 ± 3.4) / 70 (7.0 ± 3.9) [0.99 (0.53) 136 (6.5 ± 3.6) / 4 (0.2 ± 0.4) \0.001 (\ 0.001)
Decreased eps
Longitudinally: total (mean) LV
segment number
49 (4.5 ± 2.8) / 32 (3.2 ± 2.3) 0.12 (0.28) 81 (3.9 ± 2.6) / 2 (0.1 ± 0.3) \0.001 (\0.001)
Circumferentially: total (mean) LV
segment number
12 (1.6 ± 1.7) / 24 (2.4 ± 1.6) 0.06 (0.32) 36 (2.0 ± 1.7) / 2 (0.1 ± 0.3) \0.001 (\0.001)
Radially: total (mean) LV segment
number
18 (1.1 ± 1.1) / 29 (2.9 ± 1.7) 0.05 (0.01) 47 (2.0 ± 1.7) / 2 (0.1 ± 0.3) \0.001 (\0.001)
LVLGE: present (segment number) 9 (2.2 ± 1.7) / 8 (2.5 ± 2.3) 0.64 (0.72) 17 (2.3 ± 2.0) / 0 (0.0 ± 0.0) \0.001 (\0.001)
LVLGE: subendocardial/midwall/
subepicardial
3/5/4 / 3/5/4 [0.99 6/10/8 / 0/0/0 \0.001
RVLGE: present (segment number) 4 (0.8 ± 1.0) / 3 (0.6 ± 1.1) [0.99 (0.80) 7 (0.7 ± 1.2) / 0 (0.0 ± 0.0) 0.009 (0.01)
Fig. 1 Late gadolinium enhancement (LGE) lesions (arrows) in (a) two-chamber apical long-axis view in 59 years old male with granulomatosis
with polyangiitis (Wegener’s) (WG) and (b) mid ventricular short axis view in 53 years old male with Churg–Straus syndrome (CSS)
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regurgitation/stenosis, increased systolic pulmonary artery
pressure, or pericardial effusion on TTE. Comparing
patients with WG and CSS, the former had higher ANCA
titre at the time of enrollment (20 (12.5–70) versus 0
(0–10); p = 0.002). Similarly, the maximally measured
ANCA titre at prior flares was higher in WG than CSS
subjects (200 (80–560) versus 0 (0–10); p \ 0.001). CRP
was similar in both groups at the time of enrollment.
Conversely, maximally measured CRP was higher in
subjects with WG, than CSS (86.7 ± 55.1 vs 37.0 ±
11.6 mg/l; p = 0.009). In CSS the actual and maximally
measured blood eosinophilia was 198 ± 128 and
6964 ± 5882 cells/ll (p \ 0.001), respectively. Compar-
ing WG patients with and without prior clinical cardiac
manifestations the differences in actual (20 (20–20) versus
30 (15–100); p = 0.59) and maximally measured PR3-
ANCA titre at prior flare(s) (180 (40–320) versus 200
(40–800), p = 0.68) were insignificant. Similarly, in CSS
Fig. 2 Intra and interobserver reproducibility of segmental longitudinal (a), circumferential (b) and radial (c) peak-systolic strain (eps)
measurements. SD standard deviation
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subjects with and without prior clinical cardiac manifes-
tations the differences in the actual (0 (0–0) versus 0
(0–20), p = 0.24) and maximally measured MPO-ANCA
titre at prior flare(s) [0 (0–0) vs 0 (0–30); p = 0.24] did not
reach statistical significance.
Cardiac magnetic resonance
LVEF, RVEF, LVEDV index and RVEDV index were
66.2 ± 5.8 %, 61.4 ± 5.7 %, 66.1 ± 6.6 ml/m2, and
68.8 ± 7.8 ml/m2, respectively. No patient demonstrated
abnormal global or regional LV or RV systolic function.
Table 3 summarizes CMR findings in CSS and WG subjects.
Comparing patients with WG and CSS, the former had higher
LV mass index (65.5 ± 8.6 vs 56.9 ± 7.8 g/m2; p = 0.02).
LV and RV LGE lesions were found in 17 and 7 patients, with
the mean number of involved segments of 2.3 ± 2.0 and
0.7 ± 1.2, respectively (Fig. 1). In CSS and WG subjects with
LVLGE the mean myocardial extent of LVLGE lesions was
2.0 ± 1.6 % and 2.3 ± 1.5 % (p = 0.65), respectively. Six
LGE lesions were classified as subendocardial, 10 as midwall
and 8 as subepicardial. In CSS and WG subjects LGE lesions
were found both in the posterior LV portion (inferior and
inferolateral wall) and in the interventricular septum (10 vs 8
segments, p = 0.77).
The extent and volume of LVLGE lesions did not correlate
with measured at prior flare(s) maximum level of CRP, ANCA
titre, white blood cell count, cumulative DEI and disease
duration (all [r]\0.2; p = NS). In CSS patients the extent and
volume of LVLGE lesions did not correlate with the maximum
level of blood eosinophilia at prior flare(s) (r\0.2, p = NS).
According to Lake Louise Criteria, no patient demonstrated
evidence of myocardial inflammation. Four patients had
localized pericardial effusion ([4 mm; all at RV free wall) and
six had abnormal localized pericardial thickening.
CMR feature tracking based strain
Feature tracking based eps was measured successfully in all
patients. Of 336 LV segments in CSS and WG patients eps
could not be determined longitudinally in 37(11 %),
circumferentially in 31(9 %), and radially in 43(13 %) LV
segments. The mean intra- and interobserver bias for seg-
mental longitudinal eps was 0.02 ± 2.01 and -0.08 ±
2.27 %, for circumferential -0.06 ± 2.34 and -0.20 ±
2.81 %, and for radial 0.07 ± 2.97 and -0.16 ± 3.38 %,
respectively (Fig. 2). In 21 healthy volunteers (11 females,
10 males, mean age 43.9 ± 10.5 years) the mean seg-
mental longitudinal, circumferential and radial eps with
5th–95th percentile range was -22.7 ± 5.1 % (-15.9;
- 31.3 %), -23.6 ± 5.6 % (-16.1; - 33.0 %), and
34.2 ± 15.7 % (19.9; 64.6 %), respectively. Of those
healthy individuals four subjects showed one LV segment
with decreased eps (two with reduced longitudinal eps and
two with reduced both circumferential and radial eps). None
of the control group demonstrated decline in eps in C2 LV
segments. Nine CSS and 8 WG subjects (p [ 0.99) dem-
onstrated decreased eps C2 LV segments and were con-
sidered as having reduced segmental eps. In patients with
CSS and WG decline in at least one of longitudinal, cir-
cumferential and radial eps was found in 66 and 70 LV
segments, respectively (p = 0.29). Longitudinal, circum-
ferential and radial eps was decreased in 49, 12 and 18 LV
segments (p \ 0.001) in CSS patients, and in 32, 24 and 29
(p = 0.48) LV segments in WG patients, respectively. The
mean segmental longitudinal eps in WG and CSS subjects
was lower than in controls (both p \ 0.01) (Table 4). If
compared to controls (a) segments with subendocardial
LGE lesions demonstrated decreased longitudinal, but
normal circumferential and radial eps (b) segments with
midwall LGE lesions showed decreased longitudinal, cir-
cumferential and radial eps, while (c) segments with sub-
epicardial LGE areas had decreased radial, but normal
longitudinal and circumferential eps (Table 4; Fig. 3).
Discussion
This is the first comprehensive CMR evaluation of
cardiac involvement in subjects with clinical remission
Table 4 The mean segmental longitudinal, circumferential and radial
peak-systolic strain (eps) in subjects with Churg–Strauss syndrome
(CSS), granulomatosis with polyangiitis (Wegener’s) (WG), controls
as well as with regard to the spatial distribution of late gadolinium
enhancement (LGE) lesions
Segmental eps CSS (n = 11) WG (n = 10) Subendocardial
LGE (n = 6)
Midwall
LGE (n = 10)
Subepicardial
LGE (n = 8)
Controls (n = 21)
Longitudinal [%] -20.2 ± 10.0* -20.4 ± 9.6* -11.8 ± 5.6* -13.2 ± 5.5* -19.7 ± 2.9 -22.7 ± 5.1
Circumferential [%] -24.0 ± 7.0 -23.5 ± 7.8 -22.6 ± 3.1 -16.6 ± 4.2* -21.9 ± 2.8 -23.6 ± 5.6
Radial [%] 30.5 ± 13.3 29.5 ± 17.3 26.8 ± 8.4 18.8 ± 8.1* 13.7 ± 8.7* 34.2 ± 15.7
* p \ 0.01 when compared to controls
No difference in mean segmental longitudinal eps between CSS and WG were found for longitudinal (p = 0.91), circumferential (p = 0.57) and
radial (p = 0.65) measurements
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of ANCA-associated small vessel necrotizing vasculitis
who have normal ECG and TTE. Despite the lack of
clinical, electrocardiological and echocardiographic signs
of cardiac disease, heart involvement in CSS and WG is
common and the majority of patients demonstrate
decreased segmental longitudinal, circumferential and
radial eps as well as nonischemic LGE lesions, which
demonstrate patchy distribution in all myocardial layers
and are not accompanied by signs of myocarditis.
Interestingly, the decline in segmental longitudinal, cir-
cumferential and/or radial eps was related to the spatial
distribution of LGE lesions, supporting the link between
the function of individual myocardial fiber layers and
measured systolic deformational parameters.
Although clinical cardiac manifestations in WG and
CSS are not common, evidence for subclinical heart
involvement during the course of these diseases is growing
[7–12]. The wide spectrum and varied prevalence of car-
diac abnormalities in small vessel necrotizing vasculitis has
been linked to disease activity [1]. Our findings indicate
that, despite the lack of cardiac symptoms and clinical
remission, the heart is frequently involved in CSS and
WG. Importantly, the majority of CSS and WG patients
demonstrate subclinical heart abnormalities, which are
not detectable by ECG and TTE. Despite normal
systolic ventricular function segmental eps was frequently
decreased and appears to be a sensitive marker of con-
tractile dysfunction. Of note, the decline in eps was found
for longitudinal, circumferential and radial measurements
suggesting the involvement of all myocardial fiber layers.
In contrast to WG, CSS patients more frequently showed
decreased segmental longitudinal eps. In addition subjects
with CSS, when compared to subjects with WG, tended to
have less segments with decreased circumferential and
radial eps. This observation may reflect propensity for
subendocardial involvement in CSS, which has been
demonstrated in subjects with impaired LVEF by both
LGE imaging and endomyocardial biopsy [9, 11, 12]. In
general, decreased segmental eps might be considered to be
an early marker of cardiac involvement in WG and CSS.
However due to limited reproducibility more restrictive
cut-off values should be proposed and validated using
repeated CMR examinations. Interestingly, the reproduc-
ibility of segmental eps measurements in the present study
is better than previously reported by Morton G et al. and
Schuster A et al. [26, 27]. This apparent difference may
have several explanations. First, unlike these prior reports
manual adjustment of endocardial border throughout the
entire cardiac cycle was performed in the current study and
segments with inaccurate endocardial border tracking or
artifacts substantially interfering with the course of strain
curve were excluded. Second, if compared to these prior
reports, the current study has higher in-plane resolution of
SSFP sequence. Finally, the present study utilized 1.5 T
scanner, which despite lower signal to noise and contrast to
noise ratios produces less field inhomogeneities during cine
imaging than 3.0 T scanner employed by Morton G et al.
[26, 28]. Importantly, the filed inhomogeneities might
affect accurate future-tracking and increase the variability
of eps measurements, however further studies are needed to
assess the issue.
A relatively frequent cardiac abnormality observed in
the present study was LGE areas distributed in RV and LV
myocardium. As previously reported the lesions were
present in all myocardial layers (subendocardial, midwall,
subepicardial) both in the posterior LV portion and inter-
ventricular septum [8, 10–12, 14, 15]. Interestingly, these
LGE areas were not associated with CMR signs of
myocardial edema or hyperemia/hyperpermeability of
capillaries, which suggests the presence of healed rather
than necrotic lesions. The presence of myocardial inflam-
mation has been previously demonstrated during the course
of active CSS and WG and the resolution of CMR evidence
of myocarditis has been reported in patients treated for
disease flare [8, 9, 14]. In this context, the CMR signs of
myocarditis in the present study may have resolved as
patients reached clinical remission. In the current report
the decline in individual segmental eps was related to the
spatial distribution of LGE lesions. Our data clearly shows
that subendocardial LGE lesions correspond with
decreased longitudinal eps, midwall LGE lesions with
decreased longitudinal, circumferential and radial eps, and
subepicardial LGE lesions with decreased radial eps. These
associations may reflect cardiac fiber orientation in each
myocardial layer and support the mechanistic link between
function of individual myocardial fiber layers and strain
values [29].
Prior studies have demonstrated variable prevalence and
extent of LGE myocardial lesions in WG and CSS. These
discrepancies may be attributed to a different clinical
profile of studied groups and/or different imaging proto-
cols. Wassmuth et al. [9]. showed that in CSS subjects with
clinical suspicion of cardiac involvement, LGE lesions
were frequent and had larger extent, than those observed in
the present report. Similarly, we have previously found in
CSS, that LVEF\50 % is usually associated with a higher
number of LV segments with LGE and that patients
with severely reduced LVEF often have extensive suben-
docardial LGE involvement [12–14]. Conversely, a lower
Fig. 3 Peak-systolic strain (eps) with regard to the spatial distribution
of late gadolinium enhancement (LGE) lesions (arrows) in subjects
with Churg–Strauss syndrome (CSS) (a, c) and granulomatosis with
polyangiitis (Wegener’s) (WG) (b). eps was decreased longitudinally
for subendocardial LGE (a), radially for subepicardial LGE (b),
and circumferentially, longitudinally and radially for midwall LGE
(c) lesions
b
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prevalence of LGE lesions has been reported in a study of
Mavrogeni et al. [10]. who performed LGE imaging, but
not cardiac function assessment in WG and CSS subjects
with no cardiac symptoms and normal ECG. The apparent
discrepancy with the present study may have several
explanations. First, Mavrogeni et al. [10]. evaluated CSS
and WG patients with both lower disease extent and shorter
disease duration. Second, their patients had no history of
cardiac disease (versus 5 such patients in the current ser-
ies). Finally, the signal intensity threshold to delineate
LGE areas set by Mavrogeni et al. [10]. was higher than
that used in studies of myocarditis, and thus potentially
reducing the ability for LGE detection [30].
Study limitations
First, the study cohort is small and these results should be
confirmed in a larger patient cohort. Second, because of the
relative contraindication to CMR, patients with low creat-
inine clearance were excluded and the results may not be
applicable to a broader population of CSS and WG
patients. Third, we have not assessed eps by TTE, what
might elucidate its role to depict early cardiac involvement
on a segmental basis and determine the potential
superiority of CMR technique. Fourth, an assessment of
myocardial velocity, displacement and strain rate, which is
available using Diogenes CMR feature tracking software,
was not performed. Fifth, myocardial perfusion abnor-
malities were not evaluated using CMR. The prior studies
and case reports have shown that first-pass perfusion might
detect subendocardial perfusion abnormalities in CSS and
WG subjects who present clinical cardiac manifestation
and/or active disease. However, the value of first-pass
perfusion CMR technique to detect myocardial involve-
ment in subjects with inactive CSS or WG, normal ECG
and TTE has not been determined [16–18]. Finally,
although endomyocardial biopsy was not performed to
exclude myocarditis, this technique has relatively poor
diagnostic accuracy due to patchy myocardial involvement
in CSS and WG.
Conclusions
Despite clinical remission, normal ECG and TTE, the heart
is frequently involved in WG and CSS. Most patients
demonstrate decreased segmental longitudinal, circumfer-
ential and radial eps as well as nonischemic LGE lesions
with patchy distribution in all myocardial layers. These
lesions are not accompanied by signs of myocarditis and
are not reflected by abnormalities during routine ECG and
TTE assessment. In WG and CSS CMR may be the most
sensitive, non-invasive diagnostic technique to detect
cardiac involvement and feature tracking cine-sequence
based CMR strain analysis allows for early detection of
myocardial contractile impairments, which may correspond
with the spatial distribution of LGE lesions.
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